|
Kapil S. Meleveedu, MDAssistant Professor of MedicineDirector, Blood and Marrow Transplantation
|
|
||||||||||
Education
Post-Graduate Training
| Degree | Institution | Major |
|---|---|---|
| MBBS | Calicut Medical College | Medicine and Surgery |
Post-Graduate Training
| Training | Institution | Specialty |
|---|---|---|
| Internship | Yale New Haven Health/Bridgeport Hospital | Internal Medicine |
| Residency | Yale New Haven Health/Bridgeport Hospital | Internal Medicine |
| Fellowship | UConn School of Medicine | Hematology/Oncology |
| Fellowship | Mayo Clinic | Blood and Marrow Transplant |
- Autologous and allogeneic blood and marrow transplant and other cellular therapies including chimeric antigen receptor therapy (CART)
- Hematological malignancies including acute leukemias such as acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and other myeloid disorders like myeloproliferative neoplasm (MPN) and myelofibrosis (MF)
- Bone marrow failure conditions like severe aplastic anemia (SAA), myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH)
- Aggressive lymphomas, plasma cell disorders
| Name & Description | Category | Role | Type | Scope | Start Year | End Year |
|---|---|---|---|---|---|---|
| American Society of Hematology (ASH) | Professional/Scientific Organization | Member | External | National | ||
| American Society of Clinical Oncology (ASCO) | Professional/Scientific Organization | Member | External | National | ||
| American Society of Transplantation and Cellular therapy (ASTCT) | Professional/Scientific Organization | Member | External | National |
Journal Articles
-
Sequential Use of Prednisolone and Cyclosporine Is Effective in the Management of Immunotherapy-Related Hemolytic Anemia.
Journal of hematology 2024 Dec;13(6):285-289
-
Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.
Blood cancer journal 2021 Mar;11(3):63
-
PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia.
Leukemia & lymphoma 2021 Mar;62(3):764-767
-
Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
Cytokine: X 2020 Dec;2(4):100035
-
Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function.
Bone marrow transplantation 2019 Nov;54(11):1775-1779
Book Chapters
-
Acute lymphoblastic leukemia (ALL)
Ferri’s Clinical Advisor
-
Acute lymphoblastic leukemia (ALL)
Ferri’s Clinical Advisor
-
Acute myeloid leukemia (AML)
Ferri’s Clinical Advisor
-
Myelodysplastic syndrome (MDS)
Ferri’s Clinical Advisor
Abstracts
-
Delaying Filgrastim Administration after Autologous Stem Cell Transplant in Patients with Multiple Myeloma
IJCCD 2022 Jun;2(Supplement 1):
-
De-Escalation of PTCy Dosing in Matched Allogenic Transplants: A Single Institution Retrospective Study
Blood 2021 Nov;138(Supplement 1):4872
-
The Cost Effectiveness of Delaying Filgrastim Administration after Autologous Stem Cell Transplant in Patients with Multiple Myeloma – a Single Institution Experience
Blood 2021 Nov;138(Supplement 1):4959
-
Methotrexate-Induced Neurotoxicity Due to Ommaya Reservoir Malfunction in a Patient with Acute Lymphoblastic Leukemia.
Clinical Lymphoma Myeloma and Leukemia.
Case Reports
-
First case report of tumor lysis syndrome and acute renal failure after selinexor use in multiple myeloma.
Leukemia & lymphoma 2021 Dec;62(14):3536-3539
-
T-cell Acute Lymphoblastic Leukemia in a Patient with Pre-existing Essential Thrombocythemia: A Case Report and Literature Review.
Leukemia research reports 2021 Jan;16100264
Conference Papers
-
Deferred Diagnosis: The Consequences of Excision Biopsy Deferral in Follicular Lymphoma. International Academy for Clinical Hematology (IACH) 7th Annual Meeting. Oral Session
Reviews
-
Acute myeloid leukemia in the medically unfit elderly patients.
Leukemia research 2023 Jul;130107306
-
Advances in measurable residual disease monitoring for adult acute lymphoblastic leukemia
Adv Cell Gene Ther. 2019 May;2(4):e67
-
Molecular and Genetic Markers in Indolent Follicular Non-Hodgkin's Lymphomas are More Effectiveness in Predicting Early Relapse and Therefore Have Better Utility in Creating Cost-Effective Surveillance Strategies
Preprint
| Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
|---|---|---|---|---|
| Cellular therapies | Talk | UConn Health Cancer Center Event | 2023 | UConn Health |
| Overview of blood and marrow transplant and other cellular therapies | Talk | Internal medicine grand rounds lecture | 2023 | UCONN Health |
| Blood and marrow transplant complications and role of ICU/critical care | Talk | PCCM grand rounds | 2023 | UCONN Health |
| Root cause analysis for all patients with delayed engraftment or graft failure at RWMC | Talk | BMT Quality meeting | 2022 | Roger Williams Medical Center. Providence, RI |
| The Cost Effectiveness of Delaying Filgrastim Administration after Autologous Stem Cell Transplant in Patients with Multiple Myeloma – a Single Institution Experience | Talk | BMT Quality meeting | 2021 | Roger Williams Medical Center. Providence, RI |
| KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma | Talk | Immuno-Oncology JC series | 2020 | Roger Williams Medical Center. Providence, RI |
| HLH with primary bone marrow lymphoma – an unusual presentation | Poster | ACP Annual Meeting, CT chapter | 2014 | Southington, CT |
| Delayed occurrence of Horner’s syndrome after chest tube removal | Poster | ACP Annual Meeting, CT chapter | 2014 | Southington, CT |
| Atypical hemolytic uremic syndrome – a rapidly emerging entity | Poster | ACP Annual Meeting, CT chapter | 2013 | Southington, CT |